Clinical Trial Update: Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients [Phase 3]

View source ↗

Summary

Company updates on the Phase 3 clinical trial evaluating the efficacy and safety of HCP1202 for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• HCP1202

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: UNKNOWN